{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T17:05:04Z","timestamp":1790960704597,"version":"4.1.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"34","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,9,13]],"date-time":"2018-09-13T00:00:00Z","timestamp":1536796800000},"content-version":"vor","delay-in-days":43,"URL":"http:\/\/www.nationalarchives.gov.uk\/doc\/open-government-licence\/version\/3\/"}],"funder":[{"name":"SBRI","award":["972228"],"award-info":[{"award-number":["972228"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1016\/j.vaccine.2018.06.039","type":"journal-article","created":{"date-parts":[[2018,7,15]],"date-time":"2018-07-15T10:29:52Z","timestamp":1531650592000},"page":"5210-5217","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Dual route vaccination for plague with emergency use applications"],"prefix":"10.1016","volume":"36","author":[{"given":"B.D.","family":"Moore","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.R.C.","family":"New","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.","family":"Butcher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Mahood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Steward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Bayliss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"MacLeod","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Bogus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.D.","family":"Williamson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2018.06.039_b0005","first-page":"5696542","article-title":"Plague: A millenary infectious disease reemerging in the XXI century","author":"Gr\u00e1cio","year":"2017","journal-title":"BioMed Res Int"},{"key":"10.1016\/j.vaccine.2018.06.039_b0010","unstructured":"WHO 2017. http:\/\/www.who.int\/csr\/don\/27-november-2017-plague-madagascar\/en\/."},{"key":"10.1016\/j.vaccine.2018.06.039_b0015","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1056\/NEJM199709043371004","article-title":"Multidrug resistance in Yersinia pestis mediated by a transferable plasmid","volume":"337","author":"Galimand","year":"1997","journal-title":"N Eng J Med"},{"issue":"1","key":"10.1016\/j.vaccine.2018.06.039_b0020","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3201\/eid0701.010106","article-title":"Transferable plasmid-mediated resistance to streptomycin in a clinical isolate of yersinia pestis","volume":"7","author":"Guiyoule","year":"2001","journal-title":"Emerg Infect Dis"},{"issue":"30","key":"10.1016\/j.vaccine.2018.06.039_b0025","doi-asserted-by":"crossref","first-page":"4175","DOI":"10.1016\/S0264-410X(01)00163-3","article-title":"Vaccination against bubonic and pneumonic plague","volume":"19","author":"Titball","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.06.039_b0030","first-page":"102","article-title":"Relation between vaccinal and allergic reactions in individuals inoculated with plague vaccine","volume":"31","author":"Kozlov","year":"1960","journal-title":"Zh Mikrobiol Epidemiol Immunobiol"},{"key":"10.1016\/j.vaccine.2018.06.039_b0035","doi-asserted-by":"crossref","first-page":"S37","DOI":"10.1093\/infdis\/129.Supplement_1.S37","article-title":"Plague immunization. V. Indirect evidence for the efficacy of plague vaccine","volume":"129","author":"Cavanaugh","year":"1974","journal-title":"J Inf Dis"},{"key":"10.1016\/j.vaccine.2018.06.039_b0040","first-page":"653","article-title":"Effectiveness of live or killed plague vaccines in man","volume":"42","author":"Meyer","year":"1970","journal-title":"Bull World Health Org"},{"key":"10.1016\/j.vaccine.2018.06.039_b0045","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2016.00602","article-title":"Plague vaccine development: Current research and future trends","author":"Verma","year":"2016","journal-title":"Front Immunol"},{"issue":"12","key":"10.1016\/j.vaccine.2018.06.039_b0050","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1586\/erv.09.129","article-title":"Prospects for new plague vaccines","volume":"8","author":"Feodorova","year":"2009","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2018.06.039_b0055","doi-asserted-by":"crossref","DOI":"10.1038\/emi.2012.34","article-title":"Plague vaccines: current developments and future propects","author":"Feodorova","year":"2012","journal-title":"Emerging Microbes Infect"},{"issue":"2","key":"10.1016\/j.vaccine.2018.06.039_b0060","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1128\/CVI.00597-12","article-title":"Evaluation of protective potential of yersinia pestis outer membrane protein antigens as possible candidates for a new-generation recombinant plague vaccine","volume":"20","author":"Erova","year":"2013","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2018.06.039_b0065","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/1471-2180-5-38","article-title":"Immunization of mice with YscF provides protection from Yersinia pestis infection","volume":"5","author":"Matson","year":"2005","journal-title":"BMC Microbiol"},{"key":"10.1016\/j.vaccine.2018.06.039_b0070","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1128\/IAI.00219-07","article-title":"yadBC of Yersinia pestis, a new virulence determinant for bubonic plague","volume":"76","author":"Forman","year":"2008","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2018.06.039_b0075","doi-asserted-by":"crossref","first-page":"3687","DOI":"10.1128\/IAI.01837-05","article-title":"The ABC transporter protein OppA provides protection against experimental Yersinia pestis infection","volume":"74","author":"Tanabe","year":"2006","journal-title":"Infect Immun"},{"issue":"6","key":"10.1016\/j.vaccine.2018.06.039_b0080","doi-asserted-by":"crossref","first-page":"3598","DOI":"10.1128\/IAI.73.6.3598-3608.2005","article-title":"Human immune response to a plague vaccine comprising recombinant F1 and V antigens","volume":"73","author":"Williamson","year":"2005","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2018.06.039_b0085","article-title":"Plague In: Vaccines for biodefense, supplement to vaccine","volume":"27","author":"Williamson","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.06.039_b0090","doi-asserted-by":"crossref","first-page":"4771","DOI":"10.1016\/j.vaccine.2011.04.084","article-title":"Recombinant (F1+V) vaccine protects macaques against pneumonic plague","volume":"29","author":"Williamson","year":"2011","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2018.06.039_b0095","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.micpath.2006.09.003","article-title":"Immunogenicity of the F1+V vaccine with the identification of potential immune correlates of protection","volume":"42","author":"Williamson","year":"2007","journal-title":"Microb Pathogen"},{"key":"10.1016\/j.vaccine.2018.06.039_b0100","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1007\/978-0-387-72124-8_35","article-title":"Cell-mediated defense against Yersinia pestis infection","volume":"603","author":"Smiley","year":"2007","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.vaccine.2018.06.039_b0105","unstructured":"Emergency use authorization of medical products and related authorities. Guidance for industry and other stakeholders. U.S. department of health and human services food and drug administration, January 2017. https:\/\/www.fda.gov\/downloads\/EmergencyPreparedness\/Counterterrorism\/MedicalCounter measures\/MCMLegalRegulatoryandPolicyFramework\/UCM493627.pdf"},{"key":"10.1016\/j.vaccine.2018.06.039_b0110","series-title":"Plague and other Yersinia infections","author":"Butler","year":"1983"},{"key":"10.1016\/j.vaccine.2018.06.039_b0115","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1128\/CMR.10.1.35","article-title":"Yersinia pestis\u2014etiologic agent of plague","volume":"10","author":"Perry","year":"1997","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.vaccine.2018.06.039_b0120","doi-asserted-by":"crossref","first-page":"4234","DOI":"10.1016\/j.vaccine.2013.09.061","article-title":"Protein coated microcrystals formulated with model antigens and modified with calcium phosphate exhibit enhanced phagocytosis and immunogenicity","volume":"32","author":"Jones","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.06.039_b0125","doi-asserted-by":"crossref","first-page":"52","DOI":"10.2174\/1874126600802010052","article-title":"New. RRC a new oil-based antigen delivery formulation for both oral and parenteral vaccination","volume":"9","author":"Domingos","year":"2008","journal-title":"The Open Drug Delivery J"},{"key":"10.1016\/j.vaccine.2018.06.039_b0130","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/mi.2012.4","article-title":"Oral tolerance to food protein","volume":"5","author":"Pabst","year":"2012","journal-title":"Mucosal Immunol"},{"key":"10.1016\/j.vaccine.2018.06.039_b0135","doi-asserted-by":"crossref","first-page":"12","DOI":"10.4061\/2010\/823710","article-title":"Peyer's patches: The immune sensors of the intestine","volume":"2010","author":"Jung","year":"2010","journal-title":"Int J Inflammation"},{"issue":"7","key":"10.1016\/j.vaccine.2018.06.039_b0140","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1358\/dof.2004.029.07.854169","article-title":"Drugs of the Future Mucosal adjuvants and delivery systems for oral and nasal vaccination","volume":"29","author":"Baudner","year":"2004","journal-title":"Drugs Fut"},{"issue":"9","key":"10.1016\/j.vaccine.2018.06.039_b0145","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1038\/ni.f.208","article-title":"Environmental cues, dendritic cells and the programming of tissue-selective lymphocyte trafficking","volume":"9","author":"Sigmundsdottir","year":"2008","journal-title":"Nat Immunol"},{"issue":"3","key":"10.1016\/j.vaccine.2018.06.039_b0150","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/ni0307-229","article-title":"Vitamins in control of lymphocyte migration","volume":"8","author":"Mebius","year":"2007","journal-title":"Nat Immunol"},{"issue":"6","key":"10.1016\/j.vaccine.2018.06.039_b0155","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1084\/jem.20031244","article-title":"Selective generation of gut-tropic T cells in gut-associated lymphoid tissue (GALT): requirement for GALT dendritic cells and adjuvant","volume":"198","author":"Johansson-Lindbom","year":"2003","journal-title":"J Exp Med"},{"issue":"6944","key":"10.1016\/j.vaccine.2018.06.039_b0160","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/nature01726","article-title":"Selective imprinting of gut-homing T cells by Peyers patch dendritic cells","volume":"424","author":"Mora","year":"2003","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.vaccine.2018.06.039_b0165","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/ni1433","article-title":"DCs metabolize sunlight-induced vitamin D3 to 'program' T cell attraction to the epidermal chemokine CCL27","volume":"8","author":"Sigmundsdottir","year":"2007","journal-title":"Nat Immunol"},{"key":"10.1016\/j.vaccine.2018.06.039_b0170","series-title":"Novel vaccine adjuvants Biomed Research International","article-title":"Supplementation with natural forms of vitamin E augments antigen-specific TH1-type immune response to tetanus toxoid","volume":"2013","author":"Radhakrishnan","year":"2013"},{"key":"10.1016\/j.vaccine.2018.06.039_b0175","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0127532","article-title":"New perspective in the formulation and characterization of didodecyldimethylammonium bromide (DMAB) stabilized poly(lactic-co-glycolic acid) (PLGA) nanoparticles","author":"Gossmann","year":"2015","journal-title":"PLOS One"},{"key":"10.1016\/j.vaccine.2018.06.039_b0180","doi-asserted-by":"crossref","unstructured":"Mulia K, Devi, Krisanti E. Interaction between dimethyldioctadecylammonium bromide-modified PLGA microspheres and hyaluronic acid. AIP Conference Proceedings 2017, 1817, 020016; https:\/\/doi.org\/10.1063\/1.4976768.","DOI":"10.1063\/1.4976768"},{"issue":"5","key":"10.1016\/j.vaccine.2018.06.039_b0185","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1021\/bm0701550","article-title":"Interaction of chitosan with cell membrane models at the air-water interface","volume":"8","author":"Pavinatto","year":"2007","journal-title":"Biomacromolecules"},{"issue":"6","key":"10.1016\/j.vaccine.2018.06.039_b0190","doi-asserted-by":"crossref","first-page":"2756","DOI":"10.4049\/jimmunol.0904013","article-title":"Cutting edge: mincle is essential for recognition and adjuvanticity of the mycobacterial cord factor and its synthetic analog trehalose-dibehenate","volume":"184","author":"Schoenen","year":"2010","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2018.06.039_b0195","doi-asserted-by":"crossref","first-page":"974","DOI":"10.3390\/toxins7030974","article-title":"Cholera toxin B: one subunit with many pharmaceutical applications","volume":"7","author":"Baldauf","year":"2015","journal-title":"Toxins"},{"issue":"1","key":"10.1016\/j.vaccine.2018.06.039_b0200","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.micpath.2006.09.003","article-title":"Immunogenicity of the rF1+rV vaccine with the identification of potential immune correlates of protection","volume":"42","author":"Williamson","year":"2007","journal-title":"Microb Pathogen"},{"key":"10.1016\/j.vaccine.2018.06.039_b0205","doi-asserted-by":"crossref","first-page":"109","DOI":"10.4269\/ajtmh.1994.51.109","article-title":"Cat-transmitted fatal pneumonic plague in a person who traveled from Colorado to Arizona","volume":"51","author":"Doll","year":"1994","journal-title":"Am J Trop Med Hyg"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X18308673?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X18308673?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:27:54Z","timestamp":1759400874000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X18308673"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":41,"journal-issue":{"issue":"34","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["S0264410X18308673"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2018.06.039","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dual route vaccination for plague with emergency use applications","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2018.06.039","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2018 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}